Mitragynine is the major alkaloid of Mitragyna speciosa (Korth.) or Kratom, a psychoactive plant widely abused in Southeast Asia. While addictive effects of the substance are emerging, adverse cognitive effects of this drug and neuropharmacological actions are insufficiently understood.
Aims:
In the present study, we investigated the effects of mitragynine on spatial learning and synaptic transmission in the CA1 region of the hippocampus.
Methods:
Male Sprague Dawley rats received daily (for 12 days) training sessions in the Morris water maze, with each session followed by treatment either with mitragynine (1, 5, or 10 mg/kg; intraperitoneally), morphine (5 mg/kg; intraperitoneally) or a vehicle. In the second experiment, we recorded field excitatory postsynaptic potentials in the hippocampal CA1 area in anesthetized rats and assessed the effects of mitragynine on baseline synaptic transmission, paired-pulse facilitation, and long-term potentiation. Gene expression of major memory- and addiction-related genes was investigated and the effects of mitragynine on Ca2+ influx was also examined in cultured primary neurons from E16–E18 rats.
Results/outcomes:
Escape latency results indicate that animals treated with mitragynine displayed a slower rate of acquisition as compared to their control counterparts. Further, mitragynine treatment significantly reduced the amplitude of baseline (i.e. non-potentiated) field excitatory postsynaptic potentials and resulted in a minor suppression of long-term potentiation in CA1. Bdnf and αCaMKII mRNA expressions in the brain were not affected and Ca2+ influx elicited by glutamate application was inhibited in neurons pre-treated with mitragynine.
Conclusions/interpretation:
These data suggest that high doses of mitragynine (5 and 10 mg/kg) cause memory deficits, possibly via inhibition of Ca2+ influx and disruption of hippocampal synaptic transmission and long-term potentiation induction.
AhmadKAzizZ (2012) Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study. J Ethnopharmacol141: 446–450.
2.
ApryaniEHidayatMTMoklasMet al. (2010) Effects of mitragynine from Mitragyna speciosa Korth leaves on working memory. J Ethnopharmacol129: 357–360.
3.
BannermanDMNiewoehnerBLyonLet al. (2008) NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory. J Neurosci28: 3623–3630.
4.
BeckettAShellardETackieA (1965) The Mitragyna species of Asia – Part IV the alkaloids of the leaves of Mitragyna speciosa Korth isolation of mitragynine and speciofoline. Planta Med13: 241–246.
5.
BennettM (2000) The concept of long-term potentiation of transmission at synapses. Prog Neurobiol60: 109–137.
6.
BlissTCollingridgeG (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature361: 31–39.
7.
BurkillIH (1935) A Dictionary of the Economic Products of the Malay Peninsula. Vol. II. pp. 1480–1483.
8.
BurkillIHHaniffM (1930) Malay village medicine. The Garden’s Bulletin Straits Settlement6: 165–207.
9.
ChittrakarnSSawangjaroenKPrasetthoSet al. (2008) Inhibitory effects of kratom leaf extract (Mitragyna speciosa Korth) on the rat gastrointestinal tract. J Ethnopharmacol116: 173–178.
10.
ChuakulWTemsiririkkulRSaralampPet al. (1995) Thai Medical Plants: The National Wisdom. Bangkok, Thailand: Amarin Printing and Publishing Ltd.
11.
DamodaranTTanBWLiaoPet al. (2018) Clitoria ternatea L root extract ameliorated the cognitive and hippocampal long-term potentiation deficits induced by chronic cerebral hypoperfusion in the rat. J Ethnopharmacol224: 381–390.
12.
de MoraesNVMorettiRAFurrEBet al (2009) Determination of mitragynine in rat plasma by LC–MS/MS: Application to pharmacokinetics. J Chromatogr877: 2593–2597.
13.
de Souza SilvaMASilvaMALenzBet al. (2013) Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism. Proc Natl Acad Sci U S A110: 15097–15102.
14.
DunlopJBowlbyMPeriRet al. (2008) High-throughput electrophysiology: An emerging paradigm for ion-channel screening and physiology. Nat Rev Drug Discov7: 358–368.
15.
EastonACLourdusamyALothEet al. (2013a) CAMK2A polymorphisms predict working memory performance in humans. Mol Psychiatry18: 850–852.
16.
EastonACLucchesiWLourdusamyAet al. (2013b) αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior. Neuropsychopharmacology38: 1636–1647.
17.
GrewalKS (1932a) Observations on the pharmacology of mitragynine. J Pharmacol Exp Ther46: 251–271.
18.
GrewalKS (1932b) The effect of mitragynine on man. Br J Med Psychol12: 41–58.
19.
HassanZMuzaimiMNavaratnamVet al. (2013) From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev37: 138–151.
20.
HazimAIMustaphaMMansorSM (2011) The effects on motor behaviour and short-term memory tasks in mice following an acute administration of Mitragyna speciosa alkaloid extract and mitragynine. J Med Plants Res5: 5810–5817.
21.
IlmieMUMansorSMAbdullahJM (2015) Behavioural and electrophysiological evidence of impaired learning and memory in male Sprague Dawley rats following subchronic exposure to standardized methanolic extract of Mitragyna speciosa Korth. Malays J Med Sci Special Issue: 45–51.
22.
ImpeySObrietanKWongSTet al. (1998) Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron21: 869–883.
23.
IsmailNIJayabalanNMansorSMet al. (2017) Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice. Addict Biol22: 967–976.
24.
IzquierdoLABarrosDMArdenghiPGet al. (2000) Different hippocampal molecular requirements for short- and long-term retrieval of one-trial avoidance learning. Behav Brain Res111: 93–98.
25.
JamilMFSubkiMFLanTMet al. (2013) The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK–N–SH neuroblastoma cell. J Ethnopharmacol148: 135–143.
26.
JanchaweeBKeawpradubNChittrakarnSet al. (2007) A high-performance liquid chromatographic method for determination of mitragynine in serum and its application to a pharmacokinetic study in rats. Biomed Chromatogr21: 176–183.
27.
JansenKLPrastCJ (1988) Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol23: 115–119.
28.
KruegelACGassawayMMKapoorAet al. (2016) Synthetic and receptor signaling explorations of the mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators. J Am Chem Soc138: 6754–6764.
29.
LeonFHabibEAdkinsJEet al. (2009) Phytochemical characterization of the leaves of Mitragyna speciosa grown in USA. Nat Prod Commun4: 907–910.
30.
LeonardASLimIAHemsworthDEet al. (1999) Calcium/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A96: 3239–3244.
31.
LiZWuCPeiGet al. (2001) Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: Possible involvement of cholinergic system. Pharmacol Biochem Behav68: 507–513.
32.
LismanJYasudaRRaghavachariS (2012) Mechanisms of CaMKII action in long-term potentiation. Nat Rev Neurosci13: 169–82.
33.
Luu-TheVPaquetNCalvoEet al. (2005) Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. BioTechnique38: 287–293.
34.
LynchMA (2004) Long-term potentiation and memory. Physiol Rev84: 87–136.
35.
MatsumotoKYamamotoLTWatanabeKet al. (2005) Inhibitory effect of mitragynine, an analgesic alkaloid from Thai herbal medicine, on neurogenic contraction of the vas deferens. Life Sci78: 187–194.
36.
MatsumotoKNaritaMMuramatsuNet al. (2014) Orally active opioid/dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice. J Pharmacol Exp Ther348: 383–392.
37.
McNamaraRKSkeltonRW (1992) Pharmacological dissociation between the spatial learning deficits produced by morphine and diazepam. Psychopharmacology108: 147–152.
38.
MüllerCPQuednowBBLourdusamyAet al. (2016) CaM kinases: From memories to addiction. Trends Pharmacol Sci37: 153–166.
39.
NiewoehnerBSingleFNHvalbyØet al. (2007) Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus. Eur J Neurosci25: 837–846.
40.
OrioLAlexandruLCravottoGet al. (2012) UAE, MAE, SFE-CO2 and classical methods for the extraction of Mitragyna speciosa leaves. Ultrason Sonochem19: 591–595.
41.
ParthasarathySRamanathanSIsmailSet al. (2010) Determination of mitragynine in plasma with solid-phase extraction and rapid HPLC–UV analysis, and its application to a pharmacokinetic study in rat. Anal Bioanal Chem397: 2023–2030.
42.
PongluxDWongseripipatanaSTakayamaHet al. (1994) A new indole alkaloid, 7 α-Hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand. Planta Med60: 580–581.
43.
RadwanskaKMedvedevNIPereiraGSet al. (2011) Mechanism for long-term memory formation when synaptic strengthening is impaired. Proc Natl Acad Sci U S A108: 18471–18475.
44.
RamanathanSParthasarathySMurugaiyahVet al. (2015) Understanding the physicochemical properties of mitragynine, a principal alkaloid of mitragyna speciosa, for preclinical evaluation. Molecules20: 4915–4927.
45.
SaidIChunNHoughtonP (1991) Ursolic acid from Mitragyna speciosa. Planta Med57: 398–398.
46.
SchöpfIEastonACSolatiJet al. (2015) αCaMKII autophosphorylation mediates neuronal activation in the hippocampal dentate gyrus after alcohol and cocaine in mice. Neurosci Lett591: 65–68.
47.
SenikMHMansorSMRammesGet al. (2012) Mitragyna speciosa Korth standardized methanol extract induced short-term potentiation of CA1 subfield in rat hippocampal slices. J Med Plants Res6: 1234–1243.
48.
ShellardEJ (1974) The alkaloids of Mitragyna with special reference to those of Mitragyna speciosa Korth. Bull Narc26: 41–55.
49.
ShellardEJ (1989) Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol25: 123–124.
50.
ShellardEJHoughtonPJReshaM (1978a) The Mitragyna species of Asia: Part XXXI: The alkaloids of Mitragyna speciosa Korth from Thailand. Planta Med34 (5): 26–36.
51.
ShellardEJHoughtonPJReshaM (1978b) The Mitragyna species of Asia: Part XXXII: The distribution of alkaloids in young plants of Mitragyna speciosa Korth grown from seed obtained from Thailand. Planta Med34: 253–263.
52.
SimonWHapfelmeierGKochsEet al. (2001) Isoflurane blocks synaptic plasticity in the mouse hippocampus. Anesthesiology94: 1058–1065.
53.
SinghDMüllerCPVicknasingamBK (2014) Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend139: 132–137.
54.
SuhaimiFWYusoffNHHassanRet al. (2016) Neurobiology of Kratom and its main alkaloid mitragynine. Brain Res Bull126: 29–40.
55.
SuwanlertS (1975) A study of kratom eaters in Thailand. Bull Narc27 (3): 21–27.
56.
TakayamaHKuriharaMKitajimaMet al. (1998) New indole alkaloids from the leaves of MalaysianMitragyna speciosa. Tetrahedron54: 8433–8440.
57.
TanguayP (2011) Kratom in Thailand. Legis Reform Drug Pol13: 1–16.
58.
Taufik HidayatMApryaniENabishahBMet al. (2010) Determination of mitragynine bound opioid receptors. Adv Med Dent Sci3: 65–70.
59.
ThomsonAM (2000) Molecular frequency filters at central synapses. Prog in Neurobio62(2): 159–196.
60.
UtarZMajidMIAdenanMIet al. (2011) Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW264 7 macrophage cells. J Ethnopharmacol136: 75–82.
61.
VicknasingamBNarayananSBengGTet al. (2010) The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Pol21: 283–288.
62.
VillersAGieseKPRisL (2014) Long-term potentiation can be induced in the CA1 region of hippocampus in the absence of αCaMKII T286-autophosphorylation. Learn Mem21: 616–626.
63.
VorheesCVWilliamsMT (2006) Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc1: 848–858.
64.
WatanabeKYanoSHorieSet al. (1997) Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor. Life Sci60: 933–942.
65.
WrayI (1907a) Biak: An opium substitute. Journal of the Federated Malay States Museums53–56.
66.
WrayI (1907b) Notes on the anti-opium remedy. Pharm J78: 453.
67.
YusoffNHSuhaimiFWVadiveluRKet al. (2016) Abuse potential and adverse cognitive effects of mitragynine (kratom). Addict Biol21: 98–110.
68.
YusoffNHMMansorSMMullerCPet al. (2018) Baclofen blocks the acquisition and expression of mitragynine-induced conditioned place preference in rats. Behav Brain Res345: 65–71.
69.
ZhengXGLiXWYangXYet al. (2002) Effects of scopolamine and physostigmine on acquisition of morphine-treated rats in Morris water maze performance. Acta Pharmacologica Sinica23: 477–480.
70.
ZhuFYanCXZhaoYet al. (2011) Effects of pre-training morphine on spatial memory acquisition and retrieval in mice. Physiol Behav104: 754–760.
71.
ZuckerRS (1989) Short-term synaptic plasticity. Annu Rev Neurosci12: 13–31.
